Aniva is among the pioneering market-maker platforms in the European Health care market that develops, produces and promotes targeted OTx for patients with autoimmune and chronic conditions.
Operator of a cloud-based biomedical analytics platform intended to support the management of chronic diseases. The company's platform supports advanced clinical research and helps bench-marking clinic outcome data across regions and countries, enabling clinical, research and policy professionals to sustain ongoing integrated care for chronic diseases.